Skip to main content

Contact Lens Solution Toxicity

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alcon
AlconFORT WORTH, TX
1 program
PureVision lenses soaked in ReNu MultiplusN/A1 trial
Active Trials
NCT00829751Completed26Est. Jun 2011
Abbott
AbbottABBOTT PARK, IL
1 program
RevitaLensN/A1 trial
Active Trials
NCT01847105Unknown54Est. May 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottRevitaLens
AlconPureVision lenses soaked in ReNu Multiplus

Clinical Trials (2)

Total enrollment: 80 patients across 2 trials

Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions

Start: Jun 2013Est. completion: May 201454 patients
N/AUnknown
NCT00829751AlconPureVision lenses soaked in ReNu Multiplus

The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility

Start: Nov 2008Est. completion: Jun 201126 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.